Press release
Bronchitis Pipeline Appears Robust With 15+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
Bronchitis Pipeline
Explore the comprehensive insights by DelveInsight and stay ahead in understanding the C Bronchitis Treatment Landscape. Click here to read more @ Bronchitis Pipeline Outlook- https://www.delveinsight.com/sample-request/bronchitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Bronchitis Pipeline Report
• In April 2025, Incyte Corporation announced a study will be conducted to compare the efficacy of axatilimab versus placebo in combination with corticosteroids as initial treatment for moderate or severe chronic graft-versus-host disease (cGVHD).
• In April 2025, Kadmon, a Sanofi Company announced a Phase 2, open-label, long-term treatment and follow-up study in subjects with cGVHD who have been previously treated with belumosudil in Study KD025-208 or Study KD025-213. Subjects will not be screened.
• DelveInsight's Bronchitis pipeline report depicts a robust space with 15+ active players working to develop 15+ pipeline therapies for Bronchitis treatment.
• The leading Bronchitis Companies such as Zambon SpA, Yuhan Corporation, Theravance Biopharma, Genentech, Inc., GlaxoSmithKline, Novartis, SolAeroMed Inc., Reata Pharmaceuticals, Inc., Pulmatrix, Pharmaxis, PharmaKing, NovaBiotics, Merck Sharp & Dohme Corp., Johnson & Johnson Pharmaceutical Research & Development, Ionis Pharmaceuticals, Inc., Incyte Corporation, EmeraMed, Daewon Pharmaceutical Co., Ltd., Chong Kun Dang Pharmaceutical, Breath Therapeutics Inc., Boehringer Ingelheim, BioMarck Pharmaceuticals, Beyond Air, AstraZeneca, APT Pharmaceuticals, Inc., Abgenix, Abbott and others.
• Promising Bronchitis Pipeline Therapies such as BN101, TQ05105 Tablet, Belumosudil, Rituximab, Prednisone, TDI01 suspension, INCA034176, Corticosteroids and others.
Discover groundbreaking developments in Bronchitis Therapies! Gain in-depth knowledge of key Bronchitis Clinical trials, emerging drugs, and market opportunities @ Bronchitis Clinical Trials Assessment- https://www.delveinsight.com/sample-request/bronchitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Bronchitis Emerging Drugs Profile
• DW 1601: Daewon Pharmaceutical
Daewon Pharmaceutical is developing DW 1601 for the treatment of Bronchitis.
The Bronchitis Pipeline Report Provides Insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Bronchitis with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Bronchitis Treatment.
• Bronchitis Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Bronchitis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Bronchitis Market
Stay informed about the Bronchitis Pipeline trends! Uncover critical updates on therapeutic innovations and their potential impact on patients and the healthcare industry @ Bronchitis Unmet Needs- https://www.delveinsight.com/sample-request/bronchitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Bronchitis Companies
Zambon SpA, Yuhan Corporation, Theravance Biopharma, Genentech, Inc., GlaxoSmithKline, Novartis, SolAeroMed Inc., Reata Pharmaceuticals, Inc., Pulmatrix, Pharmaxis, PharmaKing, NovaBiotics, Merck Sharp & Dohme Corp., Johnson & Johnson Pharmaceutical Research & Development, Ionis Pharmaceuticals, Inc., Incyte Corporation, EmeraMed, Daewon Pharmaceutical Co., Ltd., Chong Kun Dang Pharmaceutical, Breath Therapeutics Inc., Boehringer Ingelheim, BioMarck Pharmaceuticals, Beyond Air, AstraZeneca, APT Pharmaceuticals, Inc., Abgenix, Abbott and others.
Bronchitis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Infusion
• Intradermal
• Intramuscular
• Intranasal
• Oral
• Parenteral
• Subcutaneous
• Topical.
• Molecule Type
Bronchitis Products have been categorized under various Molecule types such as
• Vaccines
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Product Type
Transform your understanding of the Bronchitis Pipeline! See the latest progress in drug development and clinical research @ Bronchitis Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/bronchitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Bronchitis Pipeline Report
• Coverage- Global
• Bronchitis Companies- Zambon SpA, Yuhan Corporation, Theravance Biopharma, Genentech, Inc., GlaxoSmithKline, Novartis, SolAeroMed Inc., Reata Pharmaceuticals, Inc., Pulmatrix, Pharmaxis, PharmaKing, NovaBiotics, Merck Sharp & Dohme Corp., Johnson & Johnson Pharmaceutical Research & Development, Ionis Pharmaceuticals, Inc., Incyte Corporation, EmeraMed, Daewon Pharmaceutical Co., Ltd., Chong Kun Dang Pharmaceutical, Breath Therapeutics Inc., Boehringer Ingelheim, BioMarck Pharmaceuticals, Beyond Air, AstraZeneca, APT Pharmaceuticals, Inc., Abgenix, Abbott and others.
• Bronchitis Pipeline Therapies- BN101, TQ05105 Tablet, Belumosudil, Rituximab, Prednisone, TDI01 suspension, INCA034176, Corticosteroids and others.
• Bronchitis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Bronchitis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Stay Ahead in Respiratory Disease Research-Access the Full Bronchitis Pipeline Analysis Today! @ Bronchitis Drugs and Companies- https://www.delveinsight.com/sample-request/bronchitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Contents
1. Introduction
2. Executive Summary
3. Bronchitis: Overview
4. Causes
5. Mechanism of Action
6. Signs and Symptoms
7. Diagnosis
8. Disease Management
9. Pipeline Therapeutics
10. Comparative Analysis
11. Therapeutic Assessment
12. Assessment by Product Type
13. Assessment by Stage and Product Type
14. Assessment by Route of Administration
15. Assessment by Stage and Route of Administration
16. Assessment by Molecule Type
17. Assessment by Stage and Molecule Type
18. Bronchitis - DelveInsight's Analytical Perspective
19. In-depth Commercial Assessment
20. Bronchitis companies' collaborations, Licensing, Acquisition -Deal Value Trends
21. Bronchitis Collaboration Deals
22. Company-Company Collaborations (Licensing / Partnering) Analysis
23. Company-University Collaborations (Licensing / Partnering) Analysis
24. Late Stage Products (Phase III)
25. Comparative Analysis
26. DW 1601: Daewon Pharmaceutical
27. Product Description
28. Research and Development
29. Product Development Activities
30. Drug profiles in the detailed report.....
31. Mid Stage Products (Phase II)
32. Comparative Analysis
33. Drug Name: Company Name
34. Product Description
35. Research and Development
36. Product Development Activities
37. Drug profiles in the detailed report.....
38. Early Stage Products (Phase I)
39. Comparative Analysis
40. Drug Name: Company Name
41. Product Description
42. Research and Development
43. Product Development Activities
44. Drug profiles in the detailed report.....
45. Pre-clinical and Discovery Stage Products
46. Comparative Analysis
47. Drug Name: Company Name
48. Product Description
49. Research and Development
50. Product Development Activities
51. Drug profiles in the detailed report.....
52. Inactive Products
53. Comparative Analysis
54. Bronchitis Key Companies
55. Bronchitis Key Products
56. Bronchitis- Unmet Needs
57. Bronchitis- Market Drivers and Barriers
58. Bronchitis- Future Perspectives and Conclusion
59. Bronchitis Analyst Views
60. Bronchitis Key Companies
61. Appendix
List of Top Selling Market Research Reports in 2025
Antibody Drug Conjugate Market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Attention Deficit Hyperactivity Disorder Market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Avascular Necrosis Market- https://www.delveinsight.com/report-store/avascular-necrosis-market
Bacterial Pneumonia Market- https://www.delveinsight.com/report-store/bacterial-pneumonia-market
Brucellosis Market- https://www.delveinsight.com/report-store/brucellosis-market
Carbapenem-resistant Enterobacteriaceae Infection Market- https://www.delveinsight.com/report-store/carbapenem-resistant-enterobacteriaceae-infection-market
Central Retinal Vein Occlusion Market- https://www.delveinsight.com/report-store/retinal-vein-occlusion-market
Chagas Disease Market- https://www.delveinsight.com/report-store/chagas-disease-market
Cone Rod Dystrophy Market- https://www.delveinsight.com/report-store/cone-rod-dystrophy-market
Digestive System Fistula Market- https://www.delveinsight.com/report-store/digestive-system-fistula-market
Elastomeric Pump Market- https://www.delveinsight.com/report-store/elastomeric-pump-market
Embolotherapy Market- https://www.delveinsight.com/report-store/embolotherapy-market
Ewing Sarcoma Market- https://www.delveinsight.com/report-store/ewing-sarcoma-market
Familial Lipoprotein Lipase Deficiency Pipeline- https://www.delveinsight.com/report-store/familial-lipoprotein-lipase-deficiency-pipeline-insight
Gastroparesis Market- https://www.delveinsight.com/report-store/gastroparesis-market
Graves Disease Market- https://www.delveinsight.com/report-store/graves-disease-market
Hdac Inhibitors Market- https://www.delveinsight.com/report-store/hdac-inhibitor-pipeline-insight
Hip Replacement Devices Market- https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
Immune Checkpoints Activator Companies- https://www.delveinsight.com/report-store/immune-checkpoints-activators
Japan Healthcare Outlook- https://www.delveinsight.com/report-store/japan-healthcare-outlook-report
Meibomian Gland Dysfunction Market- https://www.delveinsight.com/report-store/meibomian-gland-dysfunction-market
Moderate To Severe Plaque Psoriasis Market- https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
Neurodermatitis Market- https://www.delveinsight.com/report-store/neurodermatitis-market
Neurofibromatosis Type 2 Market- https://www.delveinsight.com/report-store/neurofibromatosis-type-2-market-insight
Nk Cell Therapy Market- https://www.delveinsight.com/report-store/nk-cell-therapy-pipeline-insight
Nocturia Market- https://www.delveinsight.com/report-store/nocturia-market
Non-muscle Invasive Bladder Cancer Market- https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-market
Nonalcoholic Steatohepatitis Market- https://www.delveinsight.com/report-store/nonalcoholic-steatohepatitis-nash-market
Opioid-related Disorders Market- https://www.delveinsight.com/report-store/opioid-related-disorders-market
Palmar Fibromatosis Market- https://www.delveinsight.com/report-store/palmar-fibromatosis-market
Peanut Allergy Market- https://www.delveinsight.com/report-store/peanut-allergy-market
Pediatric Growth Hormone Deficiency Market- https://www.delveinsight.com/report-store/pediatric-growth-hormone-deficiency-market
Perennial Allergic Rhinitis Market- https://www.delveinsight.com/report-store/perennial-allergic-rhinitis-market
Phototherapies For Psoriasis Market- https://www.delveinsight.com/report-store/phototherapy-devices-market
Pleural Effusion Market- https://www.delveinsight.com/report-store/pleural-effusion-market
Postpartum Depression Market- https://www.delveinsight.com/report-store/postpartum-depression-ppd-market
Primary Mediastinal Large B-cell Lymphoma Market- https://www.delveinsight.com/report-store/primary-mediastinal-large-b-cell-lymphoma-market
Psoriasis Vulgaris Market- https://www.delveinsight.com/report-store/psoriasis-vulgaris-market
Relapsing Refractory Multiple Myeloma Market- https://www.delveinsight.com/report-store/relapsing-refractory-multiple-myeloma-market
Restless Legs Syndrome Market- https://www.delveinsight.com/report-store/restless-leg-syndrome-market
Rosacea Market - https://www.delveinsight.com/report-store/rosacea-market
Scabies Market- https://www.delveinsight.com/report-store/scabies-market
Seasonal Allergic Rhinitis Market- https://www.delveinsight.com/report-store/allergic-rhinitis-market
Surgical Bleeding Market- https://www.delveinsight.com/report-store/surgical-bleeding-market
Syphilis Market- https://www.delveinsight.com/report-store/syphilis-market
Systemic Inflammatory Response Syndrome Market- https://www.delveinsight.com/report-store/systemic-inflammatory-response-syndrome-market
Tay-sachs Market- https://www.delveinsight.com/report-store/tay-sachs-disease-market
Tendinopathy Market- https://www.delveinsight.com/report-store/tendinopathy-market
Tendonitis Market- https://www.delveinsight.com/report-store/tendonitis-market
Trauma Fixation Devices Market- https://www.delveinsight.com/report-store/trauma-devices-market
Trichotillomania Market- https://www.delveinsight.com/report-store/trichotillomania-ttm-market
Uncomplicated Urinary Tract Infection Market- https://www.delveinsight.com/report-store/uncomplicated-urinary-tract-infection-uuti-market
Urinary Retention Market- https://www.delveinsight.com/report-store/urinary-retention-market
Urothelial Carcinoma Market- https://www.delveinsight.com/report-store/urothelial-carcinoma-market
Uveitis Market- https://www.delveinsight.com/report-store/uveitis-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bronchitis Pipeline Appears Robust With 15+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight here
News-ID: 4081653 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Bronchitis
Rising Respiratory Disease Incidence Sparks Robust Growth In Bronchitis Treatmen …
The Bronchitis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Bronchitis Treatment Market?
The market for bronchitis treatments has seen robust expansion in the past few years, with projections showing an increase from $5.61 billion in 2024 to…
Acute Bronchitis Treatment Market: An In-Depth Analysis
The global Acute Bronchitis Treatment market was valued at approximately USD 6.3 billion in 2023 and is projected to reach around USD 9.9 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 5.3% during the forecast period.
Acute Bronchitis Treatment Market Overview
Acute bronchitis is a common respiratory condition characterized by inflammation of the bronchial tubes, leading to symptoms such as coughing and mucus production. The market's growth…
Bronchitis Treatment Market Statistical Forecast, Trade Analysis 2024 - 2031
DataM Intelligence has published a new research report on "Bronchitis Treatment Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF -…
Bronchitis Treatment Market Outlook, Insights, Size 2024-2033
The bronchitis treatment market size has grown strongly in recent years. It will grow from $5.25 billion in 2023 to $5.58 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising air pollution levels, cigarette smoking epidemic, increased respiratory infections, environmental and occupational exposures, lifestyle factors..
The bronchitis treatment market size is expected to see strong…
Acute Bronchitis Treatment Market: What are the key opportunities?
The report attempts to offer high-quality and accurate analysis of the global Acute Bronchitis Treatment Market, keeping in view market forecasts, competitive intelligence, and technological risks and advancements, and other important subjects. Its carefully crafted market intelligence allows market participants to understand the most significant developments in the global Acute Bronchitis Treatment market that are impacting their business. Readers can become aware of crucial opportunities available in the global Acute…
Bronchitis Market: Study Navigating the Future Growth Outlook
Global Bronchitis Market Report 2019 - Market Size, Share, Price, Trend and Forecast is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Bronchitis Market. Some of the key players profiled in the study are…
